R&D Pipeline
At Senores Pharmaceuticals, we are always working on innovating new and effective solutions that meet the complex and increasing demands of the patients and the industry. Our in-house R&D team dedicates their expertise and experience to develop, test, and perfect new products according to the new demands of the market.
USA Market
| Products | R&D | Scale Up | ANDA Preparation | ANDA Filed | ANDA Approved |
|---|---|---|---|---|---|
| Amphetamine Sulfate Tablets USP, 5 mg and 10 mg |
|
||||
| Hydroxychloroquine Sulfate Tablets USP, 200 mg |
|
||||
|
Ketoconazole Tablets USP, 200 mg |
|
||||
|
Chlorzoxazone Tablets USP, 250 mg |
|
||||
| Butalbital, Acetaminophen and Caffeine Capsules USP, 50mg; 300mg; 40mg and 50mg; 325mg; 40mg |
|
||||
| Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg |
|
||||
| Butalbital and Acetaminophen Tablets USP, 50 mg; 300 mg, 25 mg; 325 mg and 50 mg; 325 mg |
|
||||
| Ketorolac Tromethamine Tablets USP, 10 mg |
|
||||
| Diclofenac Potassium Tablets USP, 25 mg and 50 mg |
|
||||
| Nicardipine Hydrochloride Capsules USP, 20 mg and 30 mg |
|
||||
| Escitalopram Tablets USP, 5 mg, 10 mg and 20 mg |
|
||||
| Product 12 |
|
||||
| Product 13 |
|
||||
| Product 14 |
|
||||
| Product 15 |
|
||||
| Product 16 |
|
||||
| Product 17 |
|
||||
| Product 18 |
|
||||
| Product 19 |
|
||||
| Product 20 |
|
||||
| Product 21 |
|
||||
| Product 22 |
|
||||
| Product 23 |
|
||||
| Product 24 |
|
||||
| Product 25 |
|
||||
| Product 26 |
|
||||
| Product 27 |
|
||||
| Product 28 |
|
||||
| Product 29 |
|
||||
Specialty Products
| Products | R&D | Scale Up | ANDA Preparation | ANDA Filed | ANDA Approved |
|---|---|---|---|---|---|
| Product 1 |
|
||||
| Product 2 |
|
||||
| Product 3 |
|
||||
| Product 4 |
|
||||
Canada Market
| Products | R&D | Scale Up | ANDA Preparation | ANDA Filed | ANDA Approved |
|---|---|---|---|---|---|
| Mexiletine Hydrochloride Capsules USP, 100 mg and 200 mg |
|
||||
| Product 2 |
|
||||